Alkem Laboratories has reported results for the fourth quarter (Q4FY26) and year ended March 31, 2026.
The company has reported 21.62% fall in its net profit at Rs 217.06 crore for the fourth quarter ended March 31, 2026 as compared to Rs 276.94 crore for the same quarter in the previous year. However, total income of the company has increased by 14.26% at Rs 2,464.13 crore for Q4FY26 as compared to Rs 2,156.53 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 22.69% fall in its net profit at Rs 236.46 crore for the fourth quarter ended March 31, 2026 as compared to Rs 305.86 crore for the same quarter in the previous year. However, total income of the company increased by 15.61% at Rs 3,803.39 crore for Q4FY26 as compared to Rs 3,289.71 crore for the corresponding quarter previous year.
For the year ended March 31, 2026, the company has reported marginal rise in its net profit at Rs 2,282.09 crore as compared to Rs 2,280.89 crore for the previous year. The total income of the company has increased by 9.64% at Rs 10,219.08 crore for year under review as compared to Rs 9,320.50 crore for year ended March 31, 2025.
For the year ended March 31, 2026, on the consolidated basis, the company has reported 6.30% rise in its net profit at Rs 2,301.80 crore as compared to Rs 2,165.48 crore for the previous year. The total income of the company increased by 13.65% at Rs 15,295.62 crore for year under review as compared to Rs 13,458.26 crore for year ended March 31, 2025.
